When comparing the two patient groups with positive and negative CD117 expression in tumor cells, we did find a trend for the CD117-positive group to have a worse OS (Figure 5C) and PFS (Figure 5D) probability, but no statistical significance was achieved. The gene discussed is KIT; the disease is neoplasm.